Influence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora

Simple item page
dc.contributor.authorAkil I.
dc.contributor.authorYilmaz O.
dc.contributor.authorKurutepe S.
dc.contributor.authorDegerli K.
dc.contributor.authorKavukcu S.
dc.date.accessioned2024-07-22T08:23:28Z
dc.date.available2024-07-22T08:23:28Z
dc.date.issued2006
dc.description.abstractEnteric flora constitutes 95% of the cells in the human body. It has been shown that the bacterial content of this flora is affected by diet and changes in nutrition. Considering that urinary tract infections (UTI) are mostly due to ascending infections from the gut flora, the importance of the elements of this flora and their characteristics becomes more evident. The aim of this study was to evaluate the influence of oral Saccharomyces boulardii (S.boulardii) intake on the number of Escherichia coli (E.coli) colonies in the colon. This study was carried out with 14 boys and 10 girls (total of 24 children) aged between 36 and 192 months (mean: 104.3±45.1 months). A commercial capsule or powder containing 5 billion colony-forming units (cfu) of S.boulardii was administered once a day for 5 days. The number of E.coli and yeast colonies was measured in the stool samples of the study group before and after the use of this drug. Before treatment, the mean number of E.coli colonies in g/ml stool was 384,625±445,744. This number decreased significantly to 6,283±20,283 after treatment (p=0.00). S.boulardii was not detected in stool before treatment and the number of colonies increased to 11,047±26,754 in g/ml stool. S.boulardii may be effective in reducing the number of E.coli colonies in stool. The influence of this finding on clinical practice such as prevention of UTI needs to be clarified by further studies. © IPNA 2006.
dc.identifier.DOI-ID10.1007/s00467-006-0088-4
dc.identifier.issn0931041X
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19558
dc.language.isoEnglish
dc.subjectAdministration, Oral
dc.subjectAdolescent
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectColon
dc.subjectColony Count, Microbial
dc.subjectDietary Supplements
dc.subjectEscherichia coli
dc.subjectFeces
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectProbiotics
dc.subjectSaccharomyces
dc.subjectUrinary Tract Infections
dc.subjectprobiotic agent
dc.subjectadolescent
dc.subjectarticle
dc.subjectbacterial colonization
dc.subjectbacteriology
dc.subjectbacterium colony
dc.subjectchild
dc.subjectclinical article
dc.subjectcolon
dc.subjectcolony forming unit
dc.subjectdrug efficacy
dc.subjectEscherichia coli
dc.subjectfeces analysis
dc.subjectfemale
dc.subjecthuman
dc.subjectintestine flora
dc.subjectintestine infection
dc.subjectmale
dc.subjectnonhuman
dc.subjectpriority journal
dc.subjectSaccharomyces boulardii
dc.subjectstatistical analysis
dc.subjecturinary tract infection
dc.titleInfluence of oral intake of Saccharomyces boulardii on Escherichia coli in enteric flora
dc.typeArticle

Files

Collections

Scopus Koleksiyonu